Invention Grant
US08377940B2 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842
失效
恶二唑衍生物及其作为代谢型谷氨酸受体增强剂-842的用途
- Patent Title: Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842
- Patent Title (中): 恶二唑衍生物及其作为代谢型谷氨酸受体增强剂-842的用途
-
Application No.: US12663371Application Date: 2008-06-05
-
Publication No.: US08377940B2Publication Date: 2013-02-19
- Inventor: Joshua Clayton , Ian Egle , James Empfield , James Folmer , Methvin Isaac , Fupeng Ma , Abdelmalik Slassi
- Applicant: Joshua Clayton , Ian Egle , James Empfield , James Folmer , Methvin Isaac , Fupeng Ma , Abdelmalik Slassi
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Kenneth F. Mitchell
- International Application: PCT/SE2008/050666 WO 20080605
- International Announcement: WO2008/150233 WO 20081211
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/4245 ; C07D413/04 ; C07D413/14
Abstract:
Compounds of Formula (I) wherein R1 and Q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
Public/Granted literature
- US20100267740A1 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842 Public/Granted day:2010-10-21
Information query
IPC分类:
